Press "Enter" to skip to content

Tag: long COVID

In a nationwide survey on COVID-19 smell loss, over 50% of respondents still have symptoms after five years

The VCU-led study highlights the pervasiveness of COVID-19 smell loss as a chronic condition rather than just a temporary symptom of infection.

Since the early stages of the COVID-19 pandemic, researchers at Virginia Commonwealth University’s School of Medicine have maintained a national database of patients affected by COVID-19 related smell loss. Their latest survey shows that more than half of respondents are still impacted by smell dysfunction five years after initial infection.

The preliminary report, published in the journal Otolaryngology–Head and Neck Surgery, represents the longest study on COVID-19 smell loss recovery to date.

“Our data shows that many people are still experiencing the health impacts of COVID-19 even several years later, and they are still looking for help for their symptoms,” said Richard Costanzo, Ph.D., a professor emeritus in the Department of Otolaryngology at the School of Medicine and co-author of the new study. “We need to find new ways to help people suffering from smell and taste disorders, whether that’s caused by COVID-19 or any future viruses.”

Comments closed

B.C. program for kids with long COVID scales back services after changes to MSP

BC-CLMF has axed group sessions with allied health specialists

For 14-year-old Geo Roy, the success of a day can be measured by whether they make it out of bed.

“Today I had a shower, which I haven’t done in three days,” they said in an interview from their home on Protection Island near Nanaimo, B.C.

Since contracting a viral illness two years ago, which they suspect was COVID-19, the previously healthy teenager has been diagnosed with multiple chronic illnesses, including myalgic encephalomyelitis, commonly known as chronic fatigue syndrome, and fibromyalgia.

Comments closed

Opinion: New government must halt NDP changes to ‘lifeline’ of care for people with long COVID

Opinion: Group medical visits play a key role in reducing the burden of care on other parts of the health system. Restricting them will not reduce demand for care but will harm patients and strain health systems

On Sept. 24, two days after the provincial election was called, the Medical Services Commission signed off on changes that restrict virtual “group medical visits” to 30 patients, down from 50, effective Nov. 1. Patient advocates have noted that this change will reduce access to care for people with many chronic health conditions. It also directly contradicts the recommendations from our research with people with long COVID.

With a new provincial government set to take its seat in the legislature, an immediate task of the new minister of health should be to review and revise the proposed changes to ensure they do not restrict patient care.

Over the past four years, we have engaged with people with long COVID to better understand barriers to health care. An estimated 36 per cent of people worldwide develop long COVID after a COVID infection, and B.C. Centre for Disease Control data from 2022 identified over 327,000 people with long COVID in B.C. Our survey, conducted in 2025 with 621 people with long COVID across Canada, found that 60 per cent of B.C.-based respondents accessed group medical visits, with many noting this was the only form of care available to them.

Comments closed

Patients worry about impact of funding changes on long COVID clinic

As of Nov. 1, the changes are expected to reduce access to specialty support and increase waits between appointments with the clinic, based on Bowen Island

The summer before she got COVID-19, Karen Price spent 10 days backpacking on Mount Edziza in northern B.C.

The ecologist and forest policy worker from Salt Spring Island spent most of her time outdoors before contracting the disease in September of 2022, leaving her bed-bound for months.

Price tested positive for 16 days and spent the next six months in bed, struggling to breathe.

“At that point, GPs didn’t really know about long COVID,” she said, adding that she ended up doing much of the research about the illness and its ­treatment options on her own.

Eventually, she was referred to the B.C. Centre for Long COVID, ME/CFS & Fibromyalgia, based on Bowen Island.

Comments closed

Long COVID patients ‘devastated’ by impending changes to virtual care access in B.C.

Changes to the Medical Services Plan are due to take effect Nov. 1

Seven years ago, Vancouver resident Katy McLean was juggling a full-time job as an urban planner, a busy social calendar, and an active outdoor lifestyle.

Nowadays, even basic chores are a challenge.

“It’s my dream just to be able to go for a walk,” she said.

“I can walk around the block. But if I want to go farther, like to a big grocery store, I need to use a mobility scooter.”

Comments closed

Abandoned, dismissed and gaslighted: there is no excuse for the way ME sufferers have been betrayed

Changes in guidance and science seem to have little impact on millions of devastated lives. It’s a shocking social crisis playing out behind closed doors

I’ve spent my working life covering neglected issues. But few are neglected like the devastating chronic condition ME/CFS (myalgic encephalomyelitis, or chronic fatigue syndrome). In severe cases, the illness shuts down people’s lives almost entirely, causing an extreme loss of energy and a wide range of physical and cognitive symptoms that can prevent patients from working, socialising and, sometimes, even moving or eating. Yet these people have been more or less airbrushed from our minds.

To find out what this neglect looks like in practice, this week I put out a call on Bluesky asking people with ME/CFS about their recent experiences of treatment. I was immediately inundated with horrifying testimonies. “I’ve just been completely abandoned”; “a 10-year waiting list for treatment”; “we’ve given up seeking medical support”; “stuck in limbo”; “I just felt utterly unheard, invalidated”. I’ve been sent hundreds of shocking and heart-rending accounts.

Comments closed

‘Outdated’ health policies surrounding Covid still pose a danger today, says U of C researcher

University of Calgary professor Mark Ungrin has dedicated years of research highlighting what he believes is of significant concern to all Canadians’ health.

He says health policy and the federal government’s response to Covid was based on outdated information, and even today that same policy remains in place.

“Unfortunately, when Covid hit, there was very little attention paid to aerosol transmission as a means of Covid infecting from one person to another,” Ungrin said. “Warnings were provided by scientists, engineers, occupational health and safety experts, many people within the medical profession, but infection control leaders really based their decisions on some fairly outdated understandings of aerosol biology and disease transmission via aerosols, and as a result, they basically assumed that it was not possible for Covid to be airborne.”

Comments closed

Why Is No One Talking About Long COVID?

More than 6 years after the COVID-19 pandemic began, its effects have continued. In March 2024, roughly 17 million adults (7% of all U.S. adults) reported currently having symptoms consistent with long COVID, a chronic condition characterized by persistent symptoms lasting 3 months or longer after infection. Long COVID can affect any system or organ in the body. Symptoms of long COVID include chronic fatigue, brain fog, difficulty concentrating, severe tiredness after exercise, lightheadedness and palpitations when standing, and many other problems. Those chronic symptoms often make it difficult for people to go to work or school.

As a result, long COVID imposes substantial disability. In fact, researchers have estimated that years lived with disability attributable to long COVID is comparable to other common diseases like Alzheimer’s and asthma. In addition to the immediate effects on patients and their families, that disability translates into profound economic losses. Economists estimated in 2022 that the costs of long COVID will result in more than $3 trillion lost to society over 5 years, either through reduced quality of life and increased medical care or through lost economic productivity.

Comments closed

New Study Provides First Evidence of Dopamine System Injury in the Brain of Long COVID Patients

Findings have important implications for the pathophysiology of key COVID symptoms and suggest new potential avenues for treatment

Toronto, ON (July 10, 2026) — A new brain imaging study led by researchers at the Centre for Addiction and Mental Health (CAMH), published in eBioMedicine, provides the strongest evidence to date that long COVID is associated with injury to dopamine-releasing neurons in the brain—a finding that may explain symptoms such as lack of motivation due to fatigue, slowed movement, and memory difficulties, and could open the door to new treatment strategies.

Long COVID is estimated to affect five per cent of the world population, including two million Canadians, and is characterized by a wide range of persistent and sometimes debilitating symptoms, including brain-related ones such as fatigue, brain fog, memory problems, or low mood, that continue for at least three months following the initial COVID-19 infection. Despite its prevalence, no evidence-based treatments currently exist, largely due to limited understanding of the underlying brain pathology.

In the new study, researchers used positron emission tomography (PET) brain imaging to measure a well-established marker of dopamine neuron integrity in people with long COVID and healthy individuals.

Comments closed

Quebec can no longer remain inactive

The author sounds the alarm on the risks posed by long COVID and demands that Quebec inject money to finance research and treatments

My daughter has been living with COVID for almost two years. She suffers day after day, without access to proper treatment. She endures overwhelming fatigue, brain fog, severe insomnia, trigeminal neuralgia and a disorder of the autonomic nervous system where her heart accelerates abnormally when she stands, causing dizziness, intense fatigue and faintness. She spends almost 20 hours a day in bed. Her husband has had to stop working to take care of her and their two children. I can’t stand by and watch her suffer.

This is not an isolated case: this suffering, sometimes present for six years, is still ignored by our health system, even though the existence of long COVID is firmly established by science.

Comments closed

Long COVID may affect 1 in 6 infected patients

Long COVID may be affecting far more Americans than current estimates suggest, with a study published last week in JAMA Network Open estimating that roughly one in six people infected with SARS-CoV-2 develop the condition, and nearly 90% go on to experience chronic health problems.

For the study, a team led by researchers at Massachusetts General Hospital analyzed health record data from 457,950 adults treated for COVID-19 (also known as postacute sequelae of SARS-CoV-2 infection, or PASC) across 58 hospitals and clinics in New England, Southeast Texas, Southern California, and Western Pennsylvania.

The researchers identified long COVID cases by detecting symptoms and conditions that emerged after infection and could not be explained by preexisting conditions.

Comments closed

1400 days with long COVID; the latest findings offering hope for a cure

Although COVID-19 is no longer a hot topic, this disease still takes a toll on thousands of people who contract the virus and develop severe long-term symptoms. A meeting was held in Québec to discuss the latest findings on long COVID.

The daughter of Sylvain Thibault and Noémie Lévesque is 17 years old. She has been living with severe symptoms of long COVID since she was 13 years old, for 1400 days. Today, this teen’s daily routine is spent in bed for half the day. “She no longer has much of a life right now,” her father laments. “Her body is holding her back.”

Comments closed

Common antidepressant can treat long COVID fatigue symptoms: study

A common and low-cost antidepressant can successfully treat fatigue associated with long COVID, according to a new study.

Co-led by researchers from McMaster University in Ontario, the study found that the drug fluvoxamine, which is commonly sold under the name Luvox, significantly reduced fatigue symptoms in a clinical trial of 399 adults with long COVID. It is one of the first times a medication has been shown to effectively treat the condition.

“This is an important step forward for patients who have been desperate for evidence‑based options,” senior author and McMaster University professor Edward Mills said in a news release.

Comments closed

Video | Doctors, patients raise awareness on Long COVID Awareness Day

Sunday marks International Long Covid Awareness Day, held annually on March 15. Six years after a global pandemic was declared, the affliction continues to be a battle for some long after their initial COVID-19 infection. The CBC’s Baneet Braich has more on the efforts to raise awareness about the illness.

Comments closed

International Long COVID Awareness Day 2026

International Long COVID Awareness Day – COVID-cautious walk

Date: Sunday, March 15, 2026

Time: 7 pm – 8 pm

Where: Ottawa City Hall (meet at the entrance, Laurier Avenue side)

Join us for a walk on International Long COVID Awareness Day, Sunday, March 15, 2026 at 7 pm. The route is wheelchair-accessible.

Comments closed

Snapshots of the unseen: How we focused Long COVID in a recent photo exhibition

“Are you sick?” the Uber driver asked. “Is that why you’re wearing a mask?”

I launched into my usual monologue, delivered to strangers weekly at this point, explaining how COVID-19 transmission is still high and that I don’t want to be reinfected to worsen my existing Long COVID.

He looked at me, puzzled, through the rearview mirror. “I haven’t heard of that before,” he said, “but you look really good!”

I awkwardly stammered that I can no longer exercise, and a few years ago I could barely leave the house, almost dropping out of my graduate school program. I listed statistics of Long COVID prevalence and the compounding risks of infections.

Comments closed

Post-COVID Brain Fog Linked to Elevated pTau-181

NEW evidence from a prospective cohort study suggests that elevated plasma phosphorylated tau (pTau-181) may be a critical biomarker in patients experiencing neurological post-acute sequelae of COVID-19 (N-PASC), particularly among essential workers.

Comments closed